查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614302

女性骨盆腔植入市場：按產品類型、適應症和最終用戶分類 - 全球預測 2025-2030

Female Pelvic Implants Market by Product Type (Vaginal Graft Implants, Vaginal Mesh Implants, Vaginal Sling), Indication (Pelvic Organ Prolapse, Stress Urinary Incontinence), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年女性骨盆腔植入市場價值為9.7232億美元，預計到2024年將達到10.1559億美元，複合年成長率為4.76%，到2030年將達到13.4729億美元。

女性骨盆腔植入市場是更廣泛的醫療設備業中的一個專業領域，專注於旨在解決骨盆器官脫垂(POP) 和壓力性尿失禁 (SUI) 等疾病的產品。由於老化、肥胖和分娩影響等因素導致這些疾病越來越普遍，因此這些植入非常重要。應用主要是支持脆弱骨盆底結構的外科手術，最終用戶包括醫院、婦科診所和專科手術中心。市場成長是由材料科學的技術進步所推動的，這些技術進步提高了植入的生物相容性和使用壽命，以及患者對手術選擇的認知和接受度的提高。醫療保健支出的增加和政府的支持措施也對市場擴張做出了積極貢獻。

主要市場統計
基準年[2023] 97232萬美元
預測年份 [2024] 1,015,590,000 美元
預測年份 [2030] 1,347.29 百萬美元
複合年成長率（%） 4.76%

然而，市場面臨嚴格的監管標準和植入後併發症等挑戰，這對製造商和消費者來說都是阻礙力。有關產品缺陷的負面宣傳和訴訟可能會削弱消費者的信心，導致市場審查更加嚴格。儘管有這些挑戰，但仍有機會瞄準醫療需求未被滿足的新興國家，並推動微創手術技術以改善病患的治療效果。創新的主要領域是開發下一代植入，這些植入物利用先進的生物材料和智慧技術來實現即時監控和調整。研究應著重於提高現有產品的安全性，並開拓新的解決方案，以縮短恢復時間並提高長期療效。

就市場特徵而言，競爭格局是由持續的研發驅動的，要求企業與醫療保健提供者建立強力的合作，並投資教育舉措以增強市場信心。公司可以透過優先考慮以患者為中心的設計和強大的上市後監測系統來追蹤產品性能和患者滿意度，從而利用成長。因此，我們專注於與研究機構合作並進入臨床試驗，使我們在這個動態的市場環境中佔據優勢。

市場動態：揭示快速發展的女性骨盆植入市場的關鍵市場洞察

供需的動態交互作用正在改變女性骨盆腔植入市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 女性骨盆腔疾病增加，人們對女性生殖和全身健康的認知不斷提高
    • 政府努力擴大婦女獲得保健和醫療服務的機會
  • 市場限制因素
    • 應對監管環境的困難和訴訟的出現
  • 市場機會
    • 安全、高性能、功能性女性骨盆腔植入的開發不斷取得進展
    • 擴大手術中心和生育診所的範圍
  • 市場挑戰
    • 缺乏訓練有素的外科醫生和績效問題

波特五力：開拓女性骨盆腔植入市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解女性骨盆腔植入市場的外部影響

外部宏觀環境因素在塑造女性骨盆腔植入市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解女性骨盆腔植入市場的競爭狀況

對女性骨盆腔植入市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣女性骨盆植入市場供應商的績效評估

FPNV 定位矩陣是評估女性骨盆植入市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃女性骨盆腔植入市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對女性骨盆植入市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 女性骨盆腔疾病的發生率不斷上升，人們對女性生殖健康和整體健康的認知不斷提高
      • 政府努力擴大婦女獲得保健和醫療服務的機會
    • 抑制因素
      • 監理條件應對困難、訴訟發生
    • 機會
      • 女性骨盆腔植入的開發不斷取得進展，安全性、性能和功能均提高
      • 在世界各地擴大手術中心和生育診所
    • 任務
      • 缺乏訓練有素的外科醫生和績效問題
  • 市場區隔分析
    • 產品類型：由於有效治療應力性尿失禁，陰道吊帶的使用範圍擴大
    • 最終用戶：醫院的綜合設施和廣泛的專家正在增加女性骨盆植入的採用。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章女性骨盆腔植入市場：依產品類型

  • 陰道植入
  • 陰道網狀植入
  • 陰道吊帶

第7章依適應症分類的女性骨盆腔植入市場

  • 骨盆器官脫垂
  • 應力性尿失禁

第8章女性骨盆植入市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第9章美洲女性骨盆腔植入市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區女性骨盆腔植入市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲女性骨盆腔植入市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Caldera Medical 與 Premier 簽署女性醫療護理和手術失禁特別契約
    • CurvaFix 融資 3,900 萬美元，用於增強治療骨盆骨折的彎曲手術設備
    • FemTherapeutics 籌集 180 萬美元，透過患者專用婦科義肢促進女性健康
  • 戰略分析和建議

公司名單

  • Advin Urology
  • B. Braun of America Inc.
  • Betatech Medical
  • Boston Scientific Corporation
  • Caldera Medical
  • CARDIOLINK SL by CB Scientific, Inc.
  • Coloplast Corp.
  • Cook Group Incorporated
  • CurvaFix, Inc.
  • Medtronic
  • Narang Medical Limited
  • Neomedic Int
  • Olympus Corporation
  • PALEX MEDICAL, SA
  • pfm Medical GmbH
  • PROMEDON GmbH
  • SARS Cousin Biotech
  • Tecomet, Inc.
  • Zimmer Biomet
  • ZSI Surgical Implants SRL
Product Code: MRR-9E71DF483B9B

The Female Pelvic Implants Market was valued at USD 972.32 million in 2023, expected to reach USD 1,015.59 million in 2024, and is projected to grow at a CAGR of 4.76%, to USD 1,347.29 million by 2030.

The market for female pelvic implants is a specialized segment within the broader medical devices industry, focusing on products designed to address conditions like pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These implants are crucial due to the increasing prevalence of these conditions, often attributed to factors such as aging populations, obesity, and childbirth effects. Applications primarily involve surgical procedures to provide support to weakened pelvic floor structures, with end-users including hospitals, gynecological clinics, and specialized surgical centers. Market growth is propelled by technological advancements in material sciences, improving implant biocompatibility and longevity, alongside increasing awareness and acceptance of surgical options among patients. Rising healthcare expenditure, coupled with supportive government initiatives, also contributes positively to market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 972.32 million
Estimated Year [2024] USD 1,015.59 million
Forecast Year [2030] USD 1,347.29 million
CAGR (%) 4.76%

However, the market faces challenges such as stringent regulatory standards and post-implant complications, which can deter both manufacturers and consumers. Negative media coverage and litigation related to product failures have sometimes undermined consumer confidence, intensifying market scrutiny. Despite these challenges, opportunities exist in targeting emerging economies with unmet medical needs and advancing minimally invasive surgical techniques that offer better patient outcomes. A key area for innovation lies in developing next-generation implants utilizing advanced biomaterials and smart technology capable of real-time monitoring and adjustments. Research should focus on both improving the safety profile of existing products and pioneering new solutions that reduce recovery times and enhance long-term efficacy.

In terms of market nature, female pelvic implants remain a competitive landscape driven by continuous R&D, requiring companies to foster strong collaborative ties with healthcare providers and invest in educational initiatives to reinforce market trust. Companies can capitalize on growth by prioritizing patient-centric designs and robust post-market surveillance systems to track product performance and patient satisfaction. Consequently, focusing on partnerships with research institutions and participating in clinical trials can provide an edge in this dynamic market environment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Female Pelvic Implants Market

The Female Pelvic Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of pelvic disorders among women and awareness about women's reproductive and overall health
    • Government initiatives to expand access to healthcare and medical services for women
  • Market Restraints
    • Difficulties in navigating the regulatory landscape and incidences of lawsuits
  • Market Opportunities
    • Ongoing advancements in developing female pelvic implants with better safety, performance, and functional features
    • Expansion of surgical centers and fertility clinics across the world
  • Market Challenges
    • Shortage of adequately trained surgeons and performance issues

Porter's Five Forces: A Strategic Tool for Navigating the Female Pelvic Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Female Pelvic Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Female Pelvic Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Female Pelvic Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Female Pelvic Implants Market

A detailed market share analysis in the Female Pelvic Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Female Pelvic Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Female Pelvic Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Female Pelvic Implants Market

A strategic analysis of the Female Pelvic Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Female Pelvic Implants Market, highlighting leading vendors and their innovative profiles. These include Advin Urology, B. Braun of America Inc., Betatech Medical, Boston Scientific Corporation, Caldera Medical, CARDIOLINK S.L. by CB Scientific, Inc., Coloplast Corp., Cook Group Incorporated, CurvaFix, Inc., Medtronic, Narang Medical Limited, Neomedic Int, Olympus Corporation, PALEX MEDICAL, S.A, pfm Medical GmbH, PROMEDON GmbH, SARS Cousin Biotech, Tecomet, Inc., Zimmer Biomet, and ZSI Surgical Implants S.R.L..

Market Segmentation & Coverage

This research report categorizes the Female Pelvic Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Vaginal Graft Implants, Vaginal Mesh Implants, and Vaginal Sling.
  • Based on Indication, market is studied across Pelvic Organ Prolapse and Stress Urinary Incontinence.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of pelvic disorders among women and awareness about women's reproductive and overall health
      • 5.1.1.2. Government initiatives to expand access to healthcare and medical services for women
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulties in navigating the regulatory landscape and incidences of lawsuits
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in developing female pelvic implants with better safety, performance, and functional features
      • 5.1.3.2. Expansion of surgical centers and fertility clinics across the world
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of adequately trained surgeons and performance issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Expanding usage of vaginal sling due to its efficacy in treating stress urinary incontinence
    • 5.2.2. End User: Emerging adoption of female pelvic implants by hospitals owing to their comprehensive facilities and wide range of specialists
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Female Pelvic Implants Market, by Product Type

  • 6.1. Introduction
  • 6.2. Vaginal Graft Implants
  • 6.3. Vaginal Mesh Implants
  • 6.4. Vaginal Sling

7. Female Pelvic Implants Market, by Indication

  • 7.1. Introduction
  • 7.2. Pelvic Organ Prolapse
  • 7.3. Stress Urinary Incontinence

8. Female Pelvic Implants Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Female Pelvic Implants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Female Pelvic Implants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Female Pelvic Implants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Caldera Medical awarded Specialty Women's Health and Surgical Incontinence contract Agreement with Premier Inc
    • 12.3.2. CurvaFix lands USD 39 million to boost curved surgical device used for pelvic fracture treatment
    • 12.3.3. FemTherapeutics Raises USD 1.8 Million To Advance Women's Health With Its Patient-Specific Gynecological Prosthetics
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advin Urology
  • 2. B. Braun of America Inc.
  • 3. Betatech Medical
  • 4. Boston Scientific Corporation
  • 5. Caldera Medical
  • 6. CARDIOLINK S.L. by CB Scientific, Inc.
  • 7. Coloplast Corp.
  • 8. Cook Group Incorporated
  • 9. CurvaFix, Inc.
  • 10. Medtronic
  • 11. Narang Medical Limited
  • 12. Neomedic Int
  • 13. Olympus Corporation
  • 14. PALEX MEDICAL, S.A
  • 15. pfm Medical GmbH
  • 16. PROMEDON GmbH
  • 17. SARS Cousin Biotech
  • 18. Tecomet, Inc.
  • 19. Zimmer Biomet
  • 20. ZSI Surgical Implants S.R.L.

LIST OF FIGURES

  • FIGURE 1. FEMALE PELVIC IMPLANTS MARKET RESEARCH PROCESS
  • FIGURE 2. FEMALE PELVIC IMPLANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FEMALE PELVIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FEMALE PELVIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FEMALE PELVIC IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FEMALE PELVIC IMPLANTS MARKET DYNAMICS
  • TABLE 7. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL GRAFT IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL MESH IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL SLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. FEMALE PELVIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. FEMALE PELVIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023